Evolva Holding S.A.
OTC: ELVAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christian Wichert
- Employees
- 50
- Headquarters
- Reinach, Switzerland
- IPO year
- 2014
- Market cap
- $518.2K
- Website
- https://www.evolva.com
Loading ELVAY…
Loading profile data…Frequently asked questions about ELVAY
What does Evolva Holding S.A. (ELVAY) do?
Evolva Holding SA is a Swiss-headquartered firm, established in 2004, that operates internationally, including in the United States. The company focuses on identifying, scientifically exploring, advancing, and bringing to market natural, bio-based ingredients. These innovative compounds are utilized across a range of sectors, such as the creatio...
Where does ELVAY trade?
Evolva Holding S.A. (ELVAY) trades on the Other OTC.
What sector is ELVAY in?
Evolva Holding S.A. (ELVAY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Evolva Holding S.A.?
Christian Wichert is the chief executive officer of Evolva Holding S.A. (ELVAY).
Where is Evolva Holding S.A. headquartered?
Evolva Holding S.A. is headquartered in Switzerland.
Does ELVAY pay a dividend?
Yes — Evolva Holding S.A. (ELVAY) paid a trailing twelve-month dividend of USD 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ELVAY go public?
Evolva Holding S.A. (ELVAY) completed its initial public offering in 2014.
Is ELVAY an ADR?
Yes — ELVAY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Evolva Holding S.A. reporting and dividends follow the underlying issuer.